,

Cancer in Organ Transplant Recipients

Specificaties
Paperback, 183 blz. | Engels
Springer Berlin Heidelberg | 0e druk, 1991
ISBN13: 9783540530206
Rubricering
Juridisch :
Springer Berlin Heidelberg 0e druk, 1991 9783540530206
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

In about 5% of all organ (kidney, liver) transplant recipients, malignancies occur as a late complication of the massive immunosuppression. The malignancies are mainly skin cancers, lymphomas and renal carcinomas. The present book discusses the possible mechanisms of this type of tumorigenesis and inquires into possibilities of prevention. In particular, the described malignancies might be of viral origin. The book informs about a completely new type of carcinogenesis. Apart from the scientific aspects, it is of great practical value.

Specificaties

ISBN13:9783540530206
Taal:Engels
Bindwijze:paperback
Aantal pagina's:183
Uitgever:Springer Berlin Heidelberg
Druk:0

Inhoudsopgave

I De Novo Cancer in Organ Transplant Patients.- Animal Models of Cancer Caused by Immunosuppression.- Malignancies in Man After Organ Transplantation.- Malignant Lymphoproliferation of Viral Origin in Transplant Patients.- Clonality of Post-transplant Lymphoproliferative Diseases.- Post-transplant Kidney Cancers and Skin Cancers (Including Kaposi’s Sarcoma).- Discussion.- II Treatment of Cancer by Organ Transplantation.- Liver Transplantation for Malignant Disease.- Bone Marrow Transplantation.- Transplantation of the Upper Gastrointestinal Organs in Malignant Diseases.- Discussion.- III Possible Causes of Cancer in Transplant Patients.- The Nordic Project on Renal Transplantation and Cancer.- Human Papillomaviruses.- Immune Response Directed Against Epstein-Barr Virus Carrier B Lymphocytes.- Carcinogenic Effects of Immunosuppressive Drugs in Man.- Influence of Blood Transfusions and Immunosuppressive Therapy on Malignancies in Renal Transplant Recipients.- Possible Causes of Cancer in Transplant Patients.- Discussion.- IV Possible Prevention of De Novo Cancer in Transplant Patients.- Post-transplant Malignancies: Clinical Preventive Measures.- Immunologic Measures: Unresponsiveness or Tolerance.- New Immunosuppressive Drugs.- Cancer Related to Organ Transplantation: Summary and Conclusions.- Discussion.

Net verschenen

Rubrieken

    Personen

      Trefwoorden

        Cancer in Organ Transplant Recipients